1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Apotex Inc - Strategic SWOT Analysis Review

Apotex Inc - Strategic SWOT Analysis Review

  • January 2017
  • -
  • Global Data
  • -
  • 38 pages

Apotex Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Apotex Inc (Apotex) is a pharmaceutical company that carries out the production and marketing of a wide range of generic pharmaceuticals. It also undertakes the research, development, manufacturing and distribution of non-prescription and private label medicines, fine chemicals and disposable plastics for medicinal use. The company focuses on providing an array of affordable medicines to patients, healthcare providers, payers and governments worldwide. The company operates through affiliates in Canada, Mexico, the US, Belgium, Czech Republic, the Netherlands, Poland, Spain, Australia, India, New Zealand, Saudi Arabia and Turkey. It also has manufacturing and distribution facilities worldwide. Apotex is headquartered in Toronto, Ontario, Canada.

Apotex Inc Key Recent Developments

Oct 03, 2016: Apotex Files Lawsuit Seeking Compensation for "Improper" Government Actions

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Table Of Contents

Apotex Inc - Strategic SWOT Analysis Review
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Section 1 - About the Company 5
Apotex Inc - Key Facts 5
Apotex Inc - Key Employees 6
Apotex Inc - Major Products and Services 7
Apotex Inc - Pharmaceutical Pipeline Products Data 9
Apotex Inc, Pipeline Products by Therapy Area 9
Apotex Inc, Pipeline Products by Development Phase 10
Apotex Inc - History 11
Apotex Inc - Company Statement 14
Apotex Inc - Locations And Subsidiaries 15
Head Office 15
Other Locations and Subsidiaries 15
Section 2 - Company Analysis 17
Apotex Inc - Business Description 17
Apotex Inc - Corporate Strategy 18
Apotex Inc - SWOT Analysis 19
SWOT Analysis - Overview 19
Apotex Inc - Strengths 19
Apotex Inc - Weaknesses 20
Apotex Inc - Opportunities 21
Apotex Inc - Threats 22
Apotex Inc - Key Competitors 23
Section 3 - Company's Lifesciences Lifesciences, Oil and Gas Oil and Gas Lifesciences Lifesciences Lifesciences Lifesciences Lifesciences Lifesciences Financial Deals and Alliances 24
Apotex Inc, Pharmaceuticals and Healthcare, Deals By Year, 2011 to YTD 2017 24
Apotex Inc, Pharmaceuticals and Healthcare, Deals By Type, 2011 to YTD 2017 25
Apotex Inc, Pharmaceuticals and Healthcare, Deals By Year, 2011 to YTD 2017 26
Apotex Inc, Pharmaceuticals and Healthcare, Deals By Type, 2011 to YTD 2017 27
Apotex Inc, Pharmaceuticals and Healthcare, Deals By Year, 2011 to YTD 2017 28
Apotex Inc, Pharmaceuticals and Healthcare, Deals By Type, 2011 to YTD 2017 29
Apotex Inc, Pharmaceuticals and Healthcare, Deals By Year, 2011 to YTD 2017 30
Apotex Inc, Pharmaceuticals and Healthcare, Deals By Type, 2011 to YTD 2017 31
Apotex Inc, Pharmaceuticals and Healthcare, Deals By Year, 2011 to YTD 2017 32
Apotex Inc, Pharmaceuticals and Healthcare, Deals By Type, 2011 to YTD 2017 33
Apotex Inc, Pharmaceuticals and Healthcare, Deals By Year, 2011 to YTD 2017 34
Apotex Inc, Pharmaceuticals and Healthcare, Deals By Type, 2011 to YTD 2017 35
Apotex Inc, Recent Deals Summary 36
Section 4 - Company's Recent Developments 37
Oct 03, 2016: Apotex Files Lawsuit Seeking Compensation for "Improper" Government Actions 37
Section 5 - Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
Apotex Inc, Key Facts 5
Apotex Inc, Key Employees 6
Apotex Inc, Major Products and Services 7
Apotex Inc, Number of Pipeline Products by Therapy Area 9
Apotex Inc, Number of Pipeline Products by Development Stage 10
Apotex Inc, History 11
Apotex Inc, Subsidiaries 15
Apotex Inc, Key Competitors 23
Apotex Inc, Pharmaceuticals and Healthcare, Deals By Year, 2011 to YTD 2017 24
Apotex Inc, Pharmaceuticals and Healthcare, Deals By Type, 2011 to YTD 2017 25
Apotex Inc, Pharmaceuticals and Healthcare, Deals By Year, 2011 to YTD 2017 26
Apotex Inc, Pharmaceuticals and Healthcare, Deals By Type, 2011 to YTD 2017 27
Apotex Inc, Pharmaceuticals and Healthcare, Deals By Year, 2011 to YTD 2017 28
Apotex Inc, Pharmaceuticals and Healthcare, Deals By Type, 2011 to YTD 2017 29
Apotex Inc, Pharmaceuticals and Healthcare, Deals By Year, 2011 to YTD 2017 30
Apotex Inc, Pharmaceuticals and Healthcare, Deals By Type, 2011 to YTD 2017 31
Apotex Inc, Pharmaceuticals and Healthcare, Deals By Year, 2011 to YTD 2017 32
Apotex Inc, Pharmaceuticals and Healthcare, Deals By Type, 2011 to YTD 2017 33
Apotex Inc, Pharmaceuticals and Healthcare, Deals By Year, 2011 to YTD 2017 34
Apotex Inc, Pharmaceuticals and Healthcare, Deals By Type, 2011 to YTD 2017 35
Apotex Inc, Recent Deals Summary 36

List of Figures
Apotex Inc, Pipeline Products by Therapy Area 9
Apotex Inc, Pipeline Products by Development Phase 10
Apotex Inc, Pharmaceuticals and Healthcare, Deals By Year, 2011 to YTD 2017 24
Apotex Inc, Pharmaceuticals and Healthcare, Deals by Type, 2011 to YTD 2017 25
Apotex Inc, Pharmaceuticals and Healthcare, Deals By Year, 2011 to YTD 2017 26
Apotex Inc, Pharmaceuticals and Healthcare, Deals by Type, 2011 to YTD 2017 27
Apotex Inc, Pharmaceuticals and Healthcare, Deals By Year, 2011 to YTD 2017 28
Apotex Inc, Pharmaceuticals and Healthcare, Deals by Type, 2011 to YTD 2017 29
Apotex Inc, Pharmaceuticals and Healthcare, Deals By Year, 2011 to YTD 2017 30
Apotex Inc, Pharmaceuticals and Healthcare, Deals by Type, 2011 to YTD 2017 31
Apotex Inc, Pharmaceuticals and Healthcare, Deals By Year, 2011 to YTD 2017 32
Apotex Inc, Pharmaceuticals and Healthcare, Deals by Type, 2011 to YTD 2017 33
Apotex Inc, Pharmaceuticals and Healthcare, Deals By Year, 2011 to YTD 2017 34
Apotex Inc, Pharmaceuticals and Healthcare, Deals by Type, 2011 to YTD 2017 35

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Metabotropic Glutamate Receptor 3 (GPRC1C or MGLUR3 or GRM3) - Pipeline Review, H2 2016

Metabotropic Glutamate Receptor 3 (GPRC1C or MGLUR3 or GRM3) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Metabotropic Glutamate Receptor 3 (GPRC1C or MGLUR3 or GRM3) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Metabotropic Glutamate Receptor 3 (GPRC1C or MGLUR3 or GRM3) - Pipeline Review, ...

C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4) - Pipeline Review, H2 2016

C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4) - Pipeline Review, H2 2016’, ...

Acyl CoA Desaturase (Fatty Acid Desaturase or Delta 9 Desaturase or Stearoyl CoA Desaturase or SCD or EC 1.14.19.1) - Pipeline Review, H2 2016

Acyl CoA Desaturase (Fatty Acid Desaturase or Delta 9 Desaturase or Stearoyl CoA Desaturase or SCD or EC 1.14.19.1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

Acyl CoA Desaturase (Fatty Acid Desaturase or Delta 9 Desaturase or Stearoyl CoA Desaturase or SCD or EC 1.14.19.1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Acyl CoA Desaturase ...


ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.